» Articles » PMID: 37048635

Analysis of Clinical Factors Associated with Medical Burden and Functional Status in Pyogenic Spine Infection

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Apr 13
PMID 37048635
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Pyogenic spinal infection (PSI) has recently been on the rise due to aging and increasing degenerative spinal disease related procedures. PSI requires long-term antibiotic treatment and is followed by sustained functional disability even after successful treatment. This study aimed to analyze the clinical factors associated with medical burden and functional status of PSI.

Methods: This retrospective study involved patients with non-postoperative PSI of thoraco-lumbo-sacral area in a single tertiary hospital. The length/cost of hospitalization with an antibiotic therapy and severity of back pain using the short form 36 (SF-36) were defined as the medical burden and functional status, respectively. We analyzed the clinical factors associated with medical burden and functional status.

Results: We enrolled 142 patients (91 males and 51 females). The length and cost of hospitalization were 55.56 ± 27.09 (7-172) days and $14,070.17 ± 9289.39 (1611.87-48,722.35), respectively. A recurrence rate of 7.7% (11/142) and significant improvement of SF-36 at six months after completion of antibiotic treatment were noted ( < 0.05). Procedure-related (OR 2.702), C-reactive protein (CRP; OR 1.062), bacteremia (OR 4.966), additional surgical treatment (OR 6.524), recurrence (OR 12.453), and paraspinal abscess (OR 5.965) for above-average length of hospitalization were observed; female (OR 4.438), CRP (OR 1.071), bacteremia (OR 4.647), additional surgical treatment (OR 6.737), recurrence (OR 22.543), and extent of lesion (OR 1.431) for above-average cost of hospitalization; leg weakness (OR 15.966), white blood cell (WBC; OR 1.116), Charlson's comorbidity index (CCI, OR 1.485), and identification of causative bacteria (OR 2.913) for below-average initial SF-36 were observed; leg weakness (OR 7.975) and WBC (OR 1.094) for below-average 6-month SF-36 were the statistically significant clinical factors in the multivariable logistic regression analysis ( < 0.05).

Conclusion: Recurrence and leg weakness were identified as the most important clinical factors for medical burden and functional status in PSI, respectively. We think that it is necessary to actively suppress recurrence and manage neurological deficits for decreasing medical burden and achieving favorable functional outcome in the treatment of PSI.

Citing Articles

Culture-Negative Native Vertebral Osteomyelitis: A Narrative Review of an Underdescribed Condition.

Alavi S, Petri F, Mahmoud O, Igwilo-Alaneme R, El Zein S, Nassr A J Clin Med. 2024; 13(19).

PMID: 39407862 PMC: 11477431. DOI: 10.3390/jcm13195802.


Risk Factors Associated with Pyogenic Spinal Infections among Intravenous Drug Users and Nonusers.

Bilolikar V, Gleason B, Kripke L, Merrill R, Whitaker C, Handal J Adv Orthop. 2024; 2024:9938159.

PMID: 39105127 PMC: 11300094. DOI: 10.1155/2024/9938159.


Retroperitoneal Continuous Local Antibiotic Perfusion for Refractory Pyogenic Vertebral Osteomyelitis: A Case Report.

Ohyama S, Inoue M, Toshi N, Okuyama K, Tokeshi S, Suzuki N Cureus. 2024; 15(12):e50636.

PMID: 38226091 PMC: 10789547. DOI: 10.7759/cureus.50636.

References
1.
Jean M, Irisson J, Gras G, Bouchand F, Simo D, Duran C . Diagnostic delay of pyogenic vertebral osteomyelitis and its associated factors. Scand J Rheumatol. 2016; 46(1):64-68. DOI: 10.3109/03009742.2016.1158314. View

2.
Kim Y, Kim J, Yi J, Choi J, Chung C, Choi U . Changes in the medical burden of pyogenic and tuberculous spondylitis between 2007 and 2016: A nationwide cohort study. J Clin Neurosci. 2020; 73:89-93. DOI: 10.1016/j.jocn.2020.01.023. View

3.
Roblot F, Besnier J, Juhel L, Vidal C, Ragot S, Bastides F . Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum. 2007; 36(5):269-77. DOI: 10.1016/j.semarthrit.2006.09.004. View

4.
Murillo O, Grau I, Lora-Tamayo J, Gomez-Junyent J, Ribera A, Tubau F . The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century. Clin Microbiol Infect. 2015; 21(3):254.e1-8. DOI: 10.1016/j.cmi.2014.09.007. View

5.
Pan Z, Cheng Z, Wang J, Zhang W, Dai M, Zhang B . Spinal Tuberculosis: Always Understand, Often Prevent, Sometime Cure. Neurospine. 2021; 18(3):648-650. PMC: 8497242. DOI: 10.14245/ns.2142788.394. View